Related Experiment Video
Updated: May 19, 2026
08:17
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
Occupational asthma: new deleterious agents at the workplace.
Catherine Lemiere1, Jacques Ameille, Piera Boschetto
1Chest Department, Sacré-Coeur Hospital, Montreal, 5400 Gouin Ouest, Montreal, Quebec H4J 1C5, Canada. catherine.lemiere@umontreal.ca
Clinics in Chest Medicine
|August 30, 2012
Summary
New occupational agents causing asthma have emerged in the last decade. Fabrication, processing, or use of these agents can influence occupational asthma outcomes.
Area of Science:
- Occupational Medicine
- Pulmonology
- Toxicology
Background:
- Occupational asthma remains a significant health concern.
- Identifying new causative agents is crucial for prevention.
- Understanding exposure pathways is key to managing risk.
Purpose of the Study:
- To summarize novel occupational agents linked to asthma in the past 10 years.
- To explore how agent processing influences asthma development.
- To provide an updated overview of occupational asthma triggers.
Main Methods:
- Literature review of studies published in the last decade.
- Categorization of newly identified occupational asthma agents.
- Analysis of case studies detailing agent fabrication, processing, and use.
Main Results:
- Identification of new categories of occupational agents causing asthma.
- Documentation of agents with and without latency periods.
- Examples illustrating the impact of specific processing methods on asthma outcomes.
Conclusions:
- The landscape of occupational asthma agents is evolving.
- Workplace exposure controls must adapt to new agents and processes.
- Further research is needed on emerging occupational asthma risks.
Related Concept Videos
01:29Asthma-I: Introduction
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
01:13Asthma III: Clinical Manifestations
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include: